creatine and tirzepatide interaction OZEMPIC: Should You Mix Them? Creatine and GLP-1 Medications: Safety

doi:10.1080/10408398.2018.1425977

17 Recent advances in pharmacological treatments Sodium-glucose cotransporter-2 inhibitors SGLT-2 inhibitors (empagliflozin and dapagliflozin) are recommended in most people with type 2 diabetes and CKD, given the strong evidence that SGLT-2 inhibitors reduce CKD progression, heart failure and the risk of atherosclerotic CV disease in people with type 2 diabetes and CKD

As such, you may recover slower or faster than an individual you know who underwent a similar procedure

Additionally, GLP-1 RAs can modulate appetite-regulating centers in the hypothalamus, such as directly activating POMC neurons [63] or inhibiting AgRP neurons by acting on GLP-1R-expressing neurons in the dorsomedial hypothalamus [61,63]

The group that moved to the 5 mg dose also fared well, maintaining a -16.6% weight loss